The fate of calcium carbonate nanoparticles administered by oral route: Absorption and their interaction with biological matrices

International Journal of Nanomedicine

Volumn 10, Issue , 2015, Pages 2273-2293

  Lee, Jeong Ai ^a   Kim, Mi Kyung ^a   Kim, Hyoung Mi ^b   Lee, Jong Kwon ^c   Jeong, Jayoung ^d   Kim, Young Rok ^e   Oh, Jae Min ^b   Choi, Soo Jin ^a  

^a Seoul Women University   (South Korea)

^b Yonsei University Wonju   (South Korea)

^c Korea Food and Drug Administration   (South Korea)

^d National Institute of Food and Drug Safety Evaluation   (South Korea)

^e Kyung Hee University   (South Korea)

Author keywords

Biokinetics; Biological interaction; Oral absorption; Protein corona; Size effect

Indexed keywords

APOLIPOPROTEIN; CALCIUM CARBONATE; CALCIUM CARBONATE NANOPARTICLE; CALCIUM ION; FIBRINOGEN; IMMUNOGLOBULIN; NANOPARTICLE; THROMBIN; UNCLASSIFIED DRUG; PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; BODY FLUID; CONTROLLED STUDY; DRUG ABSORPTION; DRUG HALF LIFE; EX VIVO STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MALE; MAXIMUM PLASMA CONCENTRATION; MOLECULAR INTERACTION; NONHUMAN; PARTICLE SIZE; PARTICULATE MATTER; PHASE TRANSITION; PHOTOCHEMICAL QUENCHING; RAT; SINGLE DRUG DOSE; TIME TO MAXIMUM PLASMA CONCENTRATION; TISSUE DISTRIBUTION; ANIMAL; FECES; INTESTINE ABSORPTION; METABOLISM; ORAL DRUG ADMINISTRATION; SPRAGUE DAWLEY RAT; TWO DIMENSIONAL GEL ELECTROPHORESIS;

RATTUS;

ADMINISTRATION, ORAL; ANIMALS; BODY FLUIDS; CALCIUM CARBONATE; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; FECES; FEMALE; INTESTINAL ABSORPTION; MALE; NANOPARTICLES; PARTICLE SIZE; PROTEINS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION;

EID: 84928168989     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S79403     Document Type: Article

References (46)

1. Reid IR, Ames RW, Evans MC, Gamble GD, Sharpe SJ. Effect of calcium supplementation on bone loss in postmenopausal women. N Engl J Med. 1993;328(7):460-464.
2. White E, Shannon JS, Patterson RE. Relationship between vitamin and calcium supplement use and colon cancer. Cancer Epidemiol Biomarkers Prev. 1997;6(10):769-774.
3. Porter C. Vitamin and mineral supplements: part 1. The Rx Consultant. 2003;12:1-8.
4. Hanzlik RP, Fowler SC, Fisher DH. Relative bioavailability of calcium from calcium formate, calcium citrate, and calcium carbonate. J Pharmacol Exp Ther. 2005;313(3):1217-1222.
5. Decktor DL, Robinson M, Maton PN, Lanza FL, Gottlieb S. Effects of aluminum/magnesium hydroxide and calcium carbonate on esophageal and gastric pH in subjects with heartburn. Am J Ther. 1995;2(8):546-552.
6. Bo-Linn GW, Davis GR, Buddrus DJ, Morawski SG, Santa Ana C, Fordtran JS. An evaluation of the importance of gastric acid secretion in the absorption of dietary calcium. J Clin Invest. 1984;73(3):640-647.
7. Park YD, Kim SY, Jang HS, et al. Towards a proteomic analysis of atopic dermatitis: a two-dimensional-polyacrylamide gel electrophoresis/mass spectrometric analysis of cultured patient-derived fibroblasts. Proteomics. 2004;4(11):3446-3455.
8. Chen HS, Chang JH, Wu JS. Calcium bioavailability of nanonized pearl powder for adults. J Food Sci. 2008;73(9):H246-H251.
9. Park HS, Jeon BJ, Ahn J, Kwak HS. Effects of nanocalcium supplemented milk on bone calcium metabolism in ovariectomized rats. Asian-australas J Anim Sci. 2007;20:1266-1271.
10. Huang S, Chen JC, Hsu CW, Chang WH. Effects of nano calcium carbonate and nano calcium citrate on toxicity in ICR mice and on bone mineral density in an ovariectomized mice model. Nanotechnology. 2009;20(37):375102.
11. Shahnazari M, Martin BR, Legette LL, Lachcik PJ, Welch J, Weaver CM. Diet calcium level but not calcium supplement particle size affects bone density and mechanical properties in ovariectomized rats. J Nutr. 2009;139(7):1308-1314.
12. Nel AE, Mädler L, Velegol D, et al. Understanding biophysicochemical interactions at the nano-bio interface. Nat Mater. 2009;8(7):543-557.
13. Tenzer S, Docter D, Kuharev J, et al. Rapid formation of plasma protein corona critically affects nanoparticle pathophysiology. Nat Nanotechnol. 2013;8(10):772-781.
14. Aggarwal P, Hall JB, McLeland CB, Dobrovolskaia MA, McNeil SE. Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy. Adv Drug Deliv Rev. 2009;61(6):428-437.
15. Sarparanta M, Bimbo LM, Rytkönen J, et al. Intravenous delivery of hydrophobin-functionalized porous silicon nanoparticles: stability, plasma protein adsorption and biodistribution. Mol Pharm. 2012;9(3):654-663.
16. Kreuter J, Shamenkov D, Petrov V, et al. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier. J Drug Target. 2002;10(4):317-325.
17. Lundqvist M, Stigler J, Elia G, Lynch I, Cedervall T, Dawson KA. Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts. Proc Natl Acad Sci U S A. 2008;105(38):14265-14270.
18. Tenzer S, Docter D, Rosfa S, et al. Nanoparticle size is a critical physicochemical determinant of the human blood plasma corona: a comprehensive quantitative proteomic analysis. ACS Nano. 2011;5(9):7155-7167.
19. Burgi BR, Pradeep T. Societal implications of nanoscience and nanotechnology in developing countries. Curr Sci. 2006;90:645-658.
20. Salata O. Applications of nanoparticles in biology and medicine. J Nanobiotechnology. 2004;2(1):3.
21. Albanese A, Tang PS, Chan WC. The effect of nanoparticle size, shape, and surface chemistry on biological systems. Annu Rev Biomed Eng. 2012;14:1-16.
22. Shukla R, Bansal V, Chaudhary M, Basu A, Bhonde RR, Sastry M. Biocompatibility of gold nanoparticles and their endocytotic fate inside the cellular compartment: a microscopic overview. Langmuir. 2005;21(23):10644-10654.
23. Harush-Frenkel O, Debotton N, Benita S, Altschuler Y. Targeting of nanoparticles to the clathrin-mediated endocytic pathway. Biochem Biophys Res Commun. 2007;353(1):26-32.
24. Choi SJ, Choy JH. Layered double hydroxide nanoparticles as target-specific delivery carriers: uptake mechanism and toxicity. Nanomedicine (Lond). 2011;6(5):803-814.
25. Govers MJ, Van der Meet R. Effects of dietary calcium and phosphate on the intestinal interactions between calcium, phosphate, fatty acids, and bile acids. Gut. 1993;34(3):365-370.
26. Peacock M. Calcium metabolism in health and disease. Clin J Am Soc Nephrol. 2010;5(Suppl 1):S23-S30.
27. Gobom J, Nordhoff E, Mirgorodskaya E, Ekman R, Roepstorff P. Sample purification and preparation technique based on nano-scale reversed-phase columns for the sensitive analysis of complex peptide mixtures by matrix-assisted laser desorption/ionization mass spectrometry. J Mass Spectrom. 1999;34(2):105-116.
28. Adler HH, Kerr PF. Infrared study of aragonite and calcite. Am Mineral. 1962;47:700-717.
29. Horiba Scientific [webpage on the Internet]. Available from: http://www.horiba.com/scientific/products/particle-characterization/education/sz-100/particle-size-by-dynamic-light-scattering-resources/what-is-z-average/. Accessed Dec 16, 2014.
30. Amankonah JO, Somasundaran P. Effects of dissolved mineral species on the electrokinetic behavior of calcite and apatite. Colloid Surf. 1985;15:335-353.
31. Sowrey FE, Skipper LJ, Pickup DM, et al. Systematic empirical analysis of calcium-oxygen coordination environment by calcium K-edge XANES. Phys Chem Chem Phys. 2004;6:188-192.
32. Bowen CE, Tang H. Conchiolin-protein in aragonite shells of mollusk. Comp Biochem Physiol. 1996;115A:269-275.
33. Compton RG, Unwin PR. The dissolution of calcite in aqueous solution at pH. 4: kinetics and mechanism. Phil Trans R Soc Lond A. 1990;330:1-45.
34. De Giudici GD. Surface control vs. diffusion control during calcite dissolution: dependence of step-edge velocity upon solution pH. Am Mineral. 2002;87:1279-1285.
35. Kurapati R, Raichur AM. Composite cyclodextrin-calcium carbonate porous microparticles and modified multilayer capsules: novel carriers for encapsulation of hydrophobic drugs. J Mater Chem B. 2013;1:3175-3184.
36. Díez-Pascual AM, Díez-Vicente AL. Poly(3-hydroxybutyrate)/ZnO bionanocomposites with improved mechanical, barrier and antibacterial properties. Int J Mol Sci. 2014;15(6):10950-10973.
37. Geng Z, He J. An effective method to significantly enhance the robustness and adhesion-to-substrate of high transmittance superamphiphobic silica thin films. J Mater Chem A. 2014;2:16601-16607.
38. Islam M, Chidembo AT, Aboutalebi SH, et al. Liquid crystalline graphene oxide/PEDOT: PSS self-assembled 3D architecture for binder-free supercapacitor electrodes. Front Energy Res. 2014;2:31. Available from: http://journal.frontiersin.org/Journal/10.3389/fenrg.2014.00031/full. Accessed February 13, 2015.
39. Lacerda SH, Park JJ, Meuse C, et al. Interaction of gold nanoparticles with common human blood proteins. ACS Nano. 2010;4(1):365-379.
40. Lai L, Lin C, Xu ZQ, et al. Spectroscopic studies on the interaction between CdTe quantum dots coated with different ligands and human serum albumin. Spectrochim Acta A. 2012;97:366-376.
41. Hu Z, Zhang H, Zhang Y, Wu R, Zou H. Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles. Colloids Surf B Biointerfaces. 2014;121:354-361.
42. Bjornson AB, Bjornson HS. Participation of immunoglobulin and the alternative complement pathway in opsonization of Bacteroides fragilis and Bacteroides thetaiotaomicron. J Infect Dis. 1978;138(3):351-358.
43. Gorbet MB, Sefton MV. Biomaterial-associated thrombosis: roles of coagulation factors, complement, platelets and leukocytes. Biomaterials. 2004;25(26):5681-5703.
44. Markiewski MM, Nilsson B, Ekdahl KN, Mollnes TE, Lambris JD. Complement and coagulation: strangers or partners in crime? Trends Immunol. 2007;28(4):184-192.
45. Oram JF, Yokoyama S. Apolipoprotein-mediated removal of cellular cholesterol and phospholipids. J Lipid Res. 1996;37(12):2473-2491.
46. Deng ZJ, Mortimer G, Schiller T, Musumeci A, Martin D, Minchin RF. Differential plasma protein binding to metal oxide nanoparticles. Nanotechnology. 2009;20(45):455101.